200 related articles for article (PubMed ID: 22740703)
21. A Raman-active competitive inhibitor of OMP decarboxylase.
Callahan BP; Bell AF; Tonge PJ; Wolfenden R
Bioorg Chem; 2006 Apr; 34(2):59-65. PubMed ID: 16457871
[TBL] [Abstract][Full Text] [Related]
22. Indiscriminate binding by orotidine 5'-phosphate decarboxylase of uridine 5'-phosphate derivatives with bulky anionic c6 substituents.
Lewis CA; Wolfenden R
Biochemistry; 2007 Nov; 46(46):13331-43. PubMed ID: 17967036
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.
Meza-Avina ME; Wei L; Buhendwa MG; Poduch E; Bello AM; Pai EF; Kotra LP
Mini Rev Med Chem; 2008 Mar; 8(3):239-47. PubMed ID: 18336344
[TBL] [Abstract][Full Text] [Related]
24. Kinetic benefits and thermal stability of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase enzyme complex in human malaria parasite Plasmodium falciparum.
Kanchanaphum P; Krungkrai J
Biochem Biophys Res Commun; 2009 Dec; 390(2):337-41. PubMed ID: 19800871
[TBL] [Abstract][Full Text] [Related]
25. Study of orotidine 5'-monophosphate decarboxylase in complex with the top three OMP, BMP, and PMP ligands by molecular dynamics simulation.
Jamshidi S; Jalili S; Rafii-Tabar H
J Biomol Struct Dyn; 2015; 33(2):404-17. PubMed ID: 24559040
[TBL] [Abstract][Full Text] [Related]
26. Structural characterization of the molecular events during a slow substrate-product transition in orotidine 5'-monophosphate decarboxylase.
Fujihashi M; Wei L; Kotra LP; Pai EF
J Mol Biol; 2009 Apr; 387(5):1199-210. PubMed ID: 19236876
[TBL] [Abstract][Full Text] [Related]
27. Chemical models and their mechanistic implications for the transformation of 6-cyanouridine 5'-monophosphate catalyzed by orotidine 5'-monophosphate decarboxylase.
Chien TC; Jen CH; Wu YJ; Liao CC
Nucleic Acids Symp Ser (Oxf); 2008; (52):297-8. PubMed ID: 18776371
[TBL] [Abstract][Full Text] [Related]
28. Drug target prioritization in Plasmodium falciparum through metabolic network analysis, and inhibitor designing using virtual screening and docking approach.
Yadav MK; Pandey SK; Swati D
J Bioinform Comput Biol; 2013 Aug; 11(4):1350003. PubMed ID: 23859267
[TBL] [Abstract][Full Text] [Related]
29. Molecular dynamic study of orotidine-5'-monophosphate decarboxylase in ground state and in intermediate state: a role of the 203-218 loop dynamics.
Hur S; Bruice TC
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9668-73. PubMed ID: 12107279
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of OMP decarboxylation in orotidine 5'-monophosphate decarboxylase.
Hu H; Boone A; Yang W
J Am Chem Soc; 2008 Nov; 130(44):14493-503. PubMed ID: 18839943
[TBL] [Abstract][Full Text] [Related]
31. Crystallization of yeast orotidine 5'-monophosphate decarboxylase complexed with 1-(5'-phospho-beta-D-ribofuranosyl) barbituric acid.
Bell JB; Jones ME; Carter CW
Proteins; 1991; 9(2):143-51. PubMed ID: 2008434
[TBL] [Abstract][Full Text] [Related]
32. A proficient enzyme: insights on the mechanism of orotidine monophosphate decarboxylase from computer simulations.
Raugei S; Cascella M; Carloni P
J Am Chem Soc; 2004 Dec; 126(48):15730-7. PubMed ID: 15571395
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the total transition state stabilization provided by amino acid side chains at orotidine 5'-monophosphate decarboxylase: a two-part substrate approach.
Barnett SA; Amyes TL; Wood BM; Gerlt JA; Richard JP
Biochemistry; 2008 Jul; 47(30):7785-7. PubMed ID: 18598058
[TBL] [Abstract][Full Text] [Related]
34. OMP decarboxylase: an experimental test of electrostatic destabilization of the enzyme-substrate complex.
Callahan BP; Wolfenden R
J Am Chem Soc; 2004 Nov; 126(45):14698-9. PubMed ID: 15535676
[TBL] [Abstract][Full Text] [Related]
35. Interrogation of the active site of OMP decarboxylase from Escherichia coli with a substrate analogue bearing an anionic group at C6.
Thirumalairajan S; Mahaney B; Bearne SL
Chem Commun (Camb); 2010 May; 46(18):3158-60. PubMed ID: 20424759
[TBL] [Abstract][Full Text] [Related]
36. Structures of the human orotidine-5'-monophosphate decarboxylase support a covalent mechanism and provide a framework for drug design.
Wittmann JG; Heinrich D; Gasow K; Frey A; Diederichsen U; Rudolph MG
Structure; 2008 Jan; 16(1):82-92. PubMed ID: 18184586
[TBL] [Abstract][Full Text] [Related]
37. Atomic resolution structure of the orotidine 5'-monophosphate decarboxylase product complex combined with surface plasmon resonance analysis: implications for the catalytic mechanism.
Fujihashi M; Mito K; Pai EF; Miki K
J Biol Chem; 2013 Mar; 288(13):9011-6. PubMed ID: 23395822
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
Bello AM; Konforte D; Poduch E; Furlonger C; Wei L; Liu Y; Lewis M; Pai EF; Paige CJ; Kotra LP
J Med Chem; 2009 Mar; 52(6):1648-58. PubMed ID: 19260677
[TBL] [Abstract][Full Text] [Related]
39. Proton transfer from C-6 of uridine 5'-monophosphate catalyzed by orotidine 5'-monophosphate decarboxylase: formation and stability of a vinyl carbanion intermediate and the effect of a 5-fluoro substituent.
Tsang WY; Wood BM; Wong FM; Wu W; Gerlt JA; Amyes TL; Richard JP
J Am Chem Soc; 2012 Sep; 134(35):14580-94. PubMed ID: 22812629
[TBL] [Abstract][Full Text] [Related]
40. Design of inhibitors of ODCase.
Mundra S; Kotra LP
Future Med Chem; 2014 Feb; 6(2):165-77. PubMed ID: 24467242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
